Analysis of Plasma EBV-DNA and Soluble Checkpoint Proteins in Nasopharyngeal Carcinoma Patients after Definitive Intensity-Modulated Radiotherapy

<p><i>ROC curve analysis of EBV-DNA levels for distinguishing between NPC patients and controls</i>. The area under the ROC curve is 0.912 (<i>p≤0.001</i>).</p>

BioMed Research International

fig3

Figure 3

Figure 3: Analysis of Plasma EBV-DNA and Soluble Checkpoint Proteins in Nasopharyngeal Carcinoma Patients after Definitive Intensity-Modulated Radiotherapy 

Figure 3 | Analysis of Plasma EBV-DNA and Soluble Checkpoint Proteins in Nasopharyngeal Carcinoma Patients after Definitive Intensity-Modulated Radiotherapy 